Generic Drug News and Research

RSS
Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.
Mylan announces U.S. launch of Prednisolone Sodium Phosphate Orally Disintegrating Tablets

Mylan announces U.S. launch of Prednisolone Sodium Phosphate Orally Disintegrating Tablets

CVS Health's net revenues increase 9.7% to $35.0B in third quarter 2014

CVS Health's net revenues increase 9.7% to $35.0B in third quarter 2014

Diabetes treatment with low-cost generic drug can have positive implications for patient's quality of life

Diabetes treatment with low-cost generic drug can have positive implications for patient's quality of life

MPI Research announces acquisition of Jasper Clinical Research & Development

MPI Research announces acquisition of Jasper Clinical Research & Development

Stiff rise in generic drug prices prompts probe by members of Congress

Stiff rise in generic drug prices prompts probe by members of Congress

Doctors, hospitals went digital, but still can't share records

Doctors, hospitals went digital, but still can't share records

Drugmakers boost generic drug prices

Drugmakers boost generic drug prices

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

Demand for $84,000 hepatitis C drug slows

Demand for $84,000 hepatitis C drug slows

Gilead to boost price of new hepatitis c drug

Gilead to boost price of new hepatitis c drug

TWi Pharmaceuticals obtains final approval from FDA for megestrol acetate 125mg/ml oral suspension

TWi Pharmaceuticals obtains final approval from FDA for megestrol acetate 125mg/ml oral suspension

Study on cancer care offers model for possible lower spending on treatment

Study on cancer care offers model for possible lower spending on treatment

First Edition: June 9, 2014

First Edition: June 9, 2014

USA witnesses dramatic slowdown in health spending growth over last decade

USA witnesses dramatic slowdown in health spending growth over last decade

Concerns rise about delays in getting generic drugs to market

Concerns rise about delays in getting generic drugs to market

Generic drug delays cost U.S. payers millions

Generic drug delays cost U.S. payers millions

Walgreens reports May sales of $6.57 billion

Walgreens reports May sales of $6.57 billion

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

U.S. Court awards Teva favorable decision for generic Celebrex

U.S. Court awards Teva favorable decision for generic Celebrex

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference